Dr. Megan Leigh Durr, MD

Dr. Durr practices at Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA.

Dr. Durr's NPI, 1790012839, was assigned on November 10, 2009. Dr. Durr graduated from The Johns Hopkins University School of Medicine in 2008. Dr. Durr holds California license A110299.

Dr. Durr's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center, at 1001 Potrero Avenue, San Francisco, CA 94110 in San Francisco County. The practice phone is (415) 206-8000.

Dr. Durr's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA. Dr. Durr is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Durr to 4 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Durr practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Durr's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Durr is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Durr is licensed in California.

CMS data shows 48 Medicare services from Dr. Durr across 3 procedure codes in 2023, for 61 Medicare patients. Medicare paid $5,904 for them.

CMS counts 61 Medicare patients who saw Dr. Durr in 2024. The largest group is 65 to 74, with 31 patients. 67% of them have high blood pressure, and 54% have high cholesterol. 64% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Durr's median patient age at 65, with 51% women.

In 2024, Dr. Durr wrote 59 Medicare Part D claims for 29 patients. 97% of them were for generic drugs. CMS names the drug for 19 of them, across 1 drug with 11 or more claims each, at $231 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Durr for performance year 2024, reported as part of a group. Dr. Durr accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Durr as offering telehealth.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 51 papers to Dr. Durr, published from 2010 to 2025. 2024 was the busiest year, with 9. The most frequent topics are Sleep Apnea, Obstructive, Otolaryngology and Endoscopy. Dr. Durr has published most often in Laryngoscope. Dr. Durr's most frequent co-authors are Jolie L. Chang, MD, Anna Katrine Meyer, MD and Whitney Chiao, MD.

CMS Open Payments shows 46 general payments to Dr. Durr from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Intersect ENT, Inc. paid the most, $1,116.

Dmand AI lists 2 awards for Dr. Durr.

Dr. Durr graduated from The Johns Hopkins University School of Medicine in 2008. Dr. Durr is a member of NHS and ACS.

Dr. Durr is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.